Trial of Enteric-Coated Camoquin in Intestinal Amebiasis

Mark T. Hoekenga
Search for other papers by Mark T. Hoekenga in
Current site
Google Scholar
PubMed Close
and
Quintin Gonzalo Maximo
Search for other papers by Quintin Gonzalo Maximo in
Current site
Google Scholar
PubMed Close
DOI:
https://doi.org/10.4269/ajtmh.1950.s1-30.625
Volume/Issue:
Volume s1-30: Issue 5
Page(s):
625–627
Restricted access
Get Permissions

Summary

Enteric-coated Camoquin proved ineffectual in the treatment of intestinal amebiasis in 15 individuals; only 4 or 27 per cent were apparently cured even with total dosages as high as 11.4 Gm. The drug was equally ineffectual in treatment of the Trichomonas hominis that 8 of these patients harbored. Two-thirds of the patients had definite symptoms of toxicity with dizziness being the most pronounced and frequent complaint. As a result of these observations, enteric-coated Camoquin is not recommended for the treatment of intestinal amebiasis.

Author Notes

Published Online:
Sep 1950
Cover The American Journal of Tropical Medicine and Hygiene
The American Journal of Tropical Medicine and Hygiene
Print ISSN:
0096-6746
Past two years Past Year Past 30 Days
Abstract Views 401 187 18
Full Text Views 2 1 0
PDF Downloads 2 2 0
 
 
 
 
Affiliate Membership Banner
 
 
Research for Health Information Banner
 
 
CLOCKSS
 
 
 
Society Publishers Coalition Banner
Save